Submitted by Anonymous (not verified) on 19 September 2024 - 14:08
Opinion/decision on a Paediatric investigation plan (PIP): Zinplava, Bezlotoxumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0135/2022
Source: